OR WAIT null SECS
March 08, 2019
The new automated cloud-based tool allows for the design of targeted single-cell DNA custom panels.
January 17, 2019
Cell and gene therapy platform company, Locate Bio, has announced that it is set to receive key patents for its IntraStem technology covering the United States and Europe
December 05, 2018
AbbVie will grant Pfizer license to launch a biosimilar to AbbVie’s Humira worldwide.
November 08, 2018
AbbVie will grant Momenta license to launch a biosimilar to AbbVie’s Humira.
October 12, 2018
Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab).
September 10, 2018
FDA, innovator companies, and biosimilar developers maneuver over exclusivity, naming, interchangeability, and more.
September 01, 2018
Although there are some similarities between the way that US and European authorities uphold antibody patents, there are also some important differences.
July 27, 2018
The National Science Foundation grant will be used to commercialize a synthetic biology platform for cancer drug development.
July 18, 2018
AbbVie will grant Mylan license to launch a biosimilar to AbbVie’s Humira.
July 01, 2018
Biosimilars and biobetters face developmental challenges to achieving commercialization.